EyePoint
(NASDAQ) EYPT
EyePoint Financials at a Glance
Market Cap
$1.17B
Revenue (TTM)
$7.62M
Net Income (TTM)
-$271.60M
EPS (TTM)
-$3.50
P/E Ratio
-3.99
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$13.93
Volume
41,715
Open
$13.20
Price
$13.93
Volume
41,715
Open
$13.20
Previous Close
$13.93
Daily Range
$13.05 - $14.18
52-Week Range
$9.40 - $19.11
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$13.93
Volume
41,715
Open
$13.20
Previous Close
$13.93
Daily Range
$13.05 - $14.18
52-Week Range
$9.40 - $19.11
Estimated Earnings Date
Aug 5, 2026
EYPT News
EYPT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout EyePoint
Industry
Pharmaceuticals
Sector
Health CareEmployees
214
CEO
Jay S. Duker, MD
Website
www.eyepointpharma.comHeadquarters
Watertown, MA 02472, US
EYPT Financials
Key Financial Metrics (TTM)
Gross Margin
76.51%
Operating Margin
-3700.89%
Net Income Margin
-3566.63%
Return on Equity
-110.54%
Return on Capital
-74.47%
Return on Assets
-94.23%
Earnings Yield
-25.06%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.17B
Shares Outstanding
83.84M
Volume
41.72K
Avg. Volume
1.07M
Financials (TTM)
Gross Profit
$5.83M
Operating Income
-$281.82M
EBITDA
-$260.06M
Operating Cash Flow
-$267.54M
Capital Expenditure
-$4.00M
Free Cash Flow
-$271.54M
Cash & ST Invst.
$222.55M
Total Debt
$20.23M
EyePoint Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$696.00K
-97.2%
Gross Profit
$168.00K
-99.3%
Gross Margin
24.14%
N/A
Market Cap
$1.17B
N/A
Market Cap/Employee
$7.10M
N/A
Employees
165
N/A
Net Income
-$84.83M
-87.7%
EBITDA
-$84.25M
-88.5%
Quarterly Fundamentals
Total Cash
$222.55M
-30.1%
Total Debt
$20.23M
-16.0%
Accounts Receivable
$1.16M
+161.8%
Inventory
$1.25M
-41.3%
Long Term Debt
$20.23M
-9.3%
Short Term Debt
$0.00
-100.0%
Return on Assets
-94.23%
N/A
Return on Invested Capital
-1.12%
N/A
Free Cash Flow
-$81.55M
-52.7%
Operating Cash Flow
-$80.55M
-51.6%